| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.42▲ | 1.42▲ | 1.43▲ | 1.50▼ | 1.55▼ |
| MA10 | 1.42▲ | 1.43▼ | 1.43▼ | 1.48▼ | 2.06▼ |
| MA20 | 1.42▲ | 1.43▼ | 1.45▼ | 1.59▼ | 2.49▼ |
| MA50 | 1.43▲ | 1.48▼ | 1.46▼ | 2.24▼ | 2.73▼ |
| MA100 | 1.43▼ | 1.46▼ | 1.48▼ | 2.56▼ | 2.36▼ |
| MA200 | 1.45▼ | 1.49▼ | 1.71▼ | 2.85▼ | 7.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.001▲ | -0.002▼ | 0.031▲ | -0.161▼ |
| RSI | 56.552▲ | 46.025▼ | 45.636▼ | 34.491▼ | 33.105▼ |
| STOCH | 36.389 | 22.576 | 43.711 | 53.533 | 5.132▼ |
| WILL %R | 0.000▲ | -68.421 | -64.286 | -65.079 | -95.473▼ |
| CCI | 108.889▲ | -68.681 | -48.443 | -61.030 | -99.032 |
| CDL | $CABA Matching Low Candlestick Pattern Detected | Set Alert |
|
Tuesday, November 03, 2026 12:00 AM
PHILADELPHIA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/26 | 1.445 | 1.495 | 1.405 | 1.43 | 2,534,384 |
| 02/11/26 | 1.52 | 1.54 | 1.38 | 1.43 | 5,685,537 |
| 30/10/26 | 1.55 | 1.585 | 1.43 | 1.51 | 3,727,615 |
| 29/10/26 | 1.54 | 1.63 | 1.54 | 1.585 | 5,382,972 |
| 28/10/26 | 1.44 | 1.53 | 1.42 | 1.52 | 5,822,600 |
| 27/10/26 | 1.33 | 1.455 | 1.32 | 1.455 | 6,628,749 |
| 26/10/26 | 1.48 | 1.48 | 1.32 | 1.35 | 6,237,002 |
| 23/10/26 | 1.50 | 1.50 | 1.39 | 1.47 | 3,991,692 |
| 22/10/26 | 1.53 | 1.555 | 1.485 | 1.52 | 2,218,656 |
| 21/10/26 | 1.61 | 1.635 | 1.51 | 1.54 | 3,044,133 |
|
|
||||
|
|
||||
|
|